Helton; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Helton; David.The latest application filed is for "treatment of exposure to chlorine gas with scopolamine".

Company Profile

5.4.19

Helton; David - Dana Point CA
Helton; David - Irvine CA
Helton; David - Newport Beach CA
HELTON; David - Foothill Ranch CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Exposure To Chlorine Gas With Scopolamine App 20220000881 - Helton; David	2022-01-06
Treatment Of Organophosphate Exposure With Ocinaplon App 20200188403 - Helton; David ; et al.	2020-06-18
Emesis treatment Grant 10,646,457 - Helton , et al.	2020-05-12
Emesis Treatment App 20190231714 - Helton; David ; et al.	2019-08-01
Emesis treatment Grant 10,206,889 - Helton , et al. Feb	2019-02-19
Emesis Treatment App 20180161287 - Helton; David ; et al.	2018-06-14
Emesis treatment Grant 9,918,949 - Helton , et al. March 20, 2	2018-03-20
Emesis Treatment App 20150005388 - Helton; David ; et al.	2015-01-01
Heteroarylthio Derivatives And Analogues App 20130289047 - Helton; David ; et al.	2013-10-31
Emesis Treatment App 20120208892 - Helton; David ; et al.	2012-08-16
Methods for Treating Cognitive/Attention Deficit Disorders Using Tetrahydroindolone Analogues and Derivatives App 20120070385 - Glasky; Alvin J. ; et al.	2012-03-22
Use Of Cyproheptadine To Treat Organophosphate Exposure App 20120065194 - HELTON; David ; et al.	2012-03-15
Treatment Of Post-traumatic Stress Disorder With Tetrahydroindolone Arylpiperzaine Compounds App 20110294823 - HELTON; David ; et al.	2011-12-01
Treatment Of Organophosphate Exposure With Tetrahydroindolone Arylpiperazine Compounds App 20110172242 - HELTON; David ; et al.	2011-07-14
Tetrahydroindolone Derivatives For Treatment Of Neurological Conditions App 20100305141 - Helton; David ; et al.	2010-12-02
Treatment Of Organophosphate Exposure With Tetrahydroindolone Arylpiperazine Compounds App 20090264443 - HELTON; David ; et al.	2009-10-22
Methods For Treating Cognitive /attention Deficit Disorders Using Tetrahydroindolone Analogues And Derivatives App 20090192319 - Glasky; Alvin J. ; et al.	2009-07-30
Treatment Of Post-traumatic Stress Disorder With Tetrahydroindolone Arylpiperzaine Compounds App 20090156609 - Helton; David ; et al.	2009-06-18
Tetrahydroindolone Derivatives for Treament of Neurological Conditions App 20070208030 - Helton; David ; et al.	2007-09-06
Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives Grant 6,982,269 - Glasky , et al. January 3, 2	2006-01-03
Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives App 20050096317 - Glasky, Alvin J. ; et al.	2005-05-05
Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives App 20030022892 - Glasky, Alvin J. ; et al.	2003-01-30

Company Registrations

DUNS

003341802

HELTON, DAVID

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.